CN118166118A - ANKRD50 gene as molecular marker of Tibetan sheep immune trait and application thereof - Google Patents
ANKRD50 gene as molecular marker of Tibetan sheep immune trait and application thereof Download PDFInfo
- Publication number
- CN118166118A CN118166118A CN202410434627.1A CN202410434627A CN118166118A CN 118166118 A CN118166118 A CN 118166118A CN 202410434627 A CN202410434627 A CN 202410434627A CN 118166118 A CN118166118 A CN 118166118A
- Authority
- CN
- China
- Prior art keywords
- tibetan sheep
- molecular marker
- gene
- ankrd50
- tibetan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001494479 Pecora Species 0.000 title claims abstract description 53
- 239000003147 molecular marker Substances 0.000 title claims abstract description 23
- 101150114985 ANKRD50 gene Proteins 0.000 title claims abstract description 11
- 239000002773 nucleotide Substances 0.000 claims abstract description 9
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 13
- 108020004414 DNA Proteins 0.000 claims description 8
- 238000009395 breeding Methods 0.000 claims description 7
- 230000001488 breeding effect Effects 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- 230000003321 amplification Effects 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 4
- 229910052737 gold Inorganic materials 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract description 13
- 102000018358 immunoglobulin Human genes 0.000 abstract description 13
- 210000000349 chromosome Anatomy 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 208000035240 Disease Resistance Diseases 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 8
- 210000000987 immune system Anatomy 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000003550 marker Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000010219 correlation analysis Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000002865 immune cell Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101150111062 C gene Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003805 procoagulant Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of molecular markers, in particular to a molecular marker of ANKRD50 gene as Tibetan sheep immune trait and application thereof. The ANKRD50 gene is used as a molecular marker of Tibetan sheep immune traits, the nucleotide sequence of the molecular marker is shown as SEQ ID NO.1, and y at 148 th position of the sequence represents T or C, so that the T/C polymorphism of the Tibetan sheep ANKRD50 gene at the position is caused. The invention can judge the immunoglobulin IgA, igG, igM content of Tibetan sheep individuals by detecting the base of 32776109 nucleotide locus on Tibetan sheep chromosome 17, and provides a new SNP molecular marker resource for the auxiliary selection of Tibetan sheep immune character markers for non-diagnostic purposes.
Description
Technical Field
The invention relates to the technical field of molecular markers, in particular to a molecular marker of ANKRD50 gene as Tibetan sheep immune trait and application thereof.
Background
In the sheep industry, the disease severely threatens the health of sheep and causes great economic loss. Although diseases can be prevented by enhancing the measures of raising management, using drug vaccines and the like, the epidemic of infectious diseases cannot be effectively controlled, and meanwhile, a large amount of drugs can cause drug resistance to animal organisms, so that hidden danger is caused to the safety of animal products.
In the long term, from the genetic basic research of disease resistance, the resistance genes are screened, the disease resistance breeding is carried out from the molecular level, the resistance of sheep to pathogens is improved from the genetic aspect, and the immunity is enhanced, so that the method is an important way for fundamentally solving the problem. The potential huge economic benefit of disease-resistant breeding and the attractive prospect of researching animal models of human diseases can be achieved, and the development of the work is being promoted vigorously. With the development of molecular biology, molecular genetics and genetic engineering techniques, disease-resistant breeding has begun to play an important role in sheep breeding.
Tibetan sheep live in Qinghai-Tibet plateau for a long time, have severe environments and need higher disease resistance to adapt to the environments. Therefore, the disease resistance of Tibetan sheep is improved, and the Tibetan sheep has stronger adaptability to severe natural environments such as high altitude, low air pressure, strong ultraviolet rays, hypoxia, cold season nutritional stress and the like.
The immune index may reflect disease resistance of the animal. The disease resistance of animals is largely dependent on the health and ability of their immune system. The primary function of the immune system is to recognize and eliminate pathogens, such as bacteria, viruses, etc., that invade the body. When a pathogen invades, the immune system reacts rapidly, initiating a series of immune response processes to fight and clear the pathogen.
Immune indicators generally include antibody levels, immune cell numbers, function, and the like. Antibodies are protein molecules produced by B cells that specifically bind to and neutralize pathogens, enhancing the effects of immune responses. The number and function of immune cells are also important indicators reflecting the state of the immune system. When the immune system is challenged, immune cells are activated and begin to proliferate to cope with pathogen invasion. These cells will differentiate further into more effector cells, such as macrophages and cytotoxic T cells, etc., to destroy the pathogen.
In addition, the disease resistance of animals is also affected by genetic factors, environmental factors, nutritional status, age, and the like. For example, genetic factors can affect the structure and function of the animal's immune system, and environmental conditions and nutritional status can affect the health and responsiveness of the immune system.
Therefore, the immune index can be used as an important reference to evaluate the disease resistance and health condition of animals. By monitoring the change of immune indexes, the immune problem of animals can be found in time, and corresponding measures are taken to improve the disease resistance of the animals and prevent and treat diseases.
Therefore, how to find the mutation site in the gene from the gene level in Tibetan sheep breeding by means of genetics, genetic engineering technology and the like, and discover the relation between the gene and the character through the association analysis between the mutation site and the character for early selection, thereby improving the seed selection efficiency and accuracy and having wide application value.
Disclosure of Invention
The invention aims at providing an ANKRD50 gene as a molecular marker of Tibetan sheep immune traits and application thereof.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides an ANKRD50 gene as a molecular marker of Tibetan sheep immune traits, wherein the nucleotide sequence of the molecular marker is shown as SEQ ID NO.1, and y at 148 th position of the sequence represents T or C, so that T/C polymorphism of the Tibetan sheep ANKRD50 gene at the position is caused.
The invention also provides a primer pair for detecting the molecular marker, and the nucleotide sequences of the primer pair are shown in SEQ ID NO.2 and SEQ ID NO. 3.
The invention also provides a method for detecting the molecular marker of the immune trait of Tibetan sheep, which comprises the following steps:
(1) Extracting Tibetan sheep genome DNA;
(2) Amplifying the genomic DNA of step (1) using the primer pair;
(3) And (3) carrying out typing identification on the polymorphic site of the amplification product obtained in the step (2).
Preferably, the amplification system of step (2) is: 22. Mu.L of PCR premix, 1. Mu.L of upstream primer, 1. Mu.L of downstream primer and 1. Mu.L of template.
Preferably, the PCR premix is gold medal Mix (green).
Preferably, the amplification in step (2) is performed by the following steps: 98 ℃ for 2min;98 ℃ for 10s,57.5 ℃ for 10s and 72 ℃ for 10s, 40 cycles in total; extending at 72℃for 2min.
The invention also provides application of the molecular marker or the primer pair or the method in-vitro detection of the Tibetan sheep immune trait for non-diagnosis purpose.
The invention also provides application of the molecular marker or the primer pair or the method in Tibetan sheep auxiliary breeding.
Preferably, the application is to screen Tibetan sheep varieties with high immunity.
Compared with the prior art, the invention has the following beneficial effects:
The invention can judge the immunoglobulin IgA, igG, igM content of Tibetan sheep individuals by detecting the base of 32776109 nucleotide locus on Tibetan sheep chromosome 17, and provides a new SNP molecular marker resource for the auxiliary selection of Tibetan sheep immune character markers for non-diagnostic purposes.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are required to be used in the embodiments or the description of the prior art will be briefly described below, and it is obvious that the drawings in the following description are only embodiments of the present invention, and that other drawings can be obtained according to the provided drawings without inventive effort for a person skilled in the art.
FIG. 1 shows PCR amplification products; wherein M represents Marker; 1. 2, 3 represent 3 sets of replicates.
FIG. 2 shows the peak pattern and sequence obtained after purification and sequencing of PCR products.
Detailed Description
The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Example 1
1 Sample collection
The sample is from Tibetan sheep group under natural grazing condition, wherein Gansu Gannan Tibetan autonomous state 40 parts, qinghai Ganya Jade Tree 45 parts, tibet autonomous region day click market 87 parts, collect 172 empty Tibetan sheep blood sample 5mL in clean procoagulant vacuum blood collection tube, stand for 30min, then 3500r/min centrifuge for 15min, suck supernatant in clean PE tube, seal and store in-20deg.C low temperature refrigerator; and collecting 5mL of blood sample in a blood collection tube added with EDTA-K2 anticoagulant, quickly and uniformly mixing the blood sample after the blood sample is collected, temporarily storing the blood sample in a sampling box containing an ice bag, and carrying the blood sample back to a laboratory for freezing and preserving the blood sample in a refrigerator at the temperature of minus 20 ℃ for DNA extraction.
2 Main reagents and instruments
EDTA-K2 vacuum blood collection tubes were purchased from Jiangsu Yuli medical instruments Co., ltd; blood genome extraction kit was purchased from tiangen biochemical technology (beijing) limited; nanoDrop 2000 spectrophotometer Thermo FISHER SCIENTIFIC, inc; DL2000 Marker, agarose, nucleic acid dye were all purchased from Beijing Soy Bao technology Co., ltd; gold medal Mix (green) was purchased from beijing engine biotechnology limited; the electrophoresis apparatus is purchased from Beijing Liuyi instrument factory; PCR instrument was purchased from BioRad corporation. IgA (E027-1-1), igG (E026-1-1), igM (E025-1-1) detection kits were purchased from Nanjing's institute of biological engineering.
3 Method
3.1 Immunoglobulin IgA, igG, igM detection
The detection kit is used for measurement by a spectrophotometry method according to IgA, igG, igM of Nanjing institute of biological engineering. Firstly, establishing a standard curve by using a standard substance; secondly, adding 7 mu L of distilled water, standard solution and sample to be detected into a blank tube, a standard tube and a measuring tube respectively, supplementing R1 solution to 900 mu L, incubating for 5min at 37 ℃, and recording the reading number as A1 at the wavelength of 340 nm; then 180. Mu.L of R2 solution is added into each tube, and the tubes are incubated for 5min at 37 ℃, and the reading number at the wavelength of 340nm is recorded as A2; finally, Δa=a2-A1 was calculated, and Δa was substituted into the standard curve equation to calculate the concentration of sample IgA, igG, igM (the specification of IgA, igG, igM detection kit describes a corresponding standard curve ;http://www.njjcbio.com/products.aspid=841;http://www.njjcbio.com/products.aspid=840;http://www.njjcbio.com/products.aspid=839).
3.2 Extraction of genomic DNA from blood
Extracting genome DNA from blood sample by adopting a blood genome extraction kit of Tiangen biochemical technology (Beijing) limited company, and placing the extracted DNA under an ultraviolet spectrophotometer to detect the concentration and purity, wherein the concentration is more than 20 ng/mu L, OD 260/OD280 and is between 1.7 and 1.9, so that the experiment requirement is met, and the DNA is stored at-20 ℃ for standby.
3.3 Primer design
Referring to the international sheep genome oar_v4.0 version 17 chromosome gene sequence (GenBank accession number: nc_ 019474.2), a pair of specific primers was designed using PRIMER PREMIER 5.0.0 software, containing g32776109T > C SNP sites.
Primer sequence:
F:5'-TCAGCTTCCTATATTTACACTGG-3'(SEQ ID NO.2);
R:5'-AAACATTCTGGAAATGGCAAA-3'(SEQ ID NO.3)。
the amplified fragment length was 499bp, and the primers were synthesized by Beijing engine biotechnology Co.
3.4 PCR amplification and sequencing
PCR amplification System 25. Mu.L: gold medal Mix (green) 22. Mu.L, 1. Mu.L each for the upstream and downstream primers, and 1. Mu.L for the template.
PCR amplification procedure: 98 ℃ for 2min;98 ℃ for 10s,57.5 ℃ for 10s and 72 ℃ for 10s, 40 cycles in total; extending at 72℃for 2min.
And detecting the PCR product by using 1.5% agarose gel electrophoresis, and after the PCR product is qualified by using the agarose gel electrophoresis detection, sequencing by using a direct sequencing method, and completing sequencing by Beijing qingke biotechnology Co. The amplified nucleotide sequence is shown as SEQ ID NO. 4. The SNP marker is positioned at 148 positions of the nucleotide sequence shown in SEQ ID NO.4, and the position can be T/C (the nucleotide sequence of the SNP marker is shown as SEQ ID NO. 1).
SEQ ID NO.4:
TCAGCTTCCTATATTTACACTGGTCTGTTTTTAACTTAATGTGTCATTACGGTGTTCTGCAAATACCATACTATTTTTTTTTTAACTTGTAAACTTCATTTTTTAGAGCATTTTTAGGTTCACTGCTTTCTTCTTAAGTGGAAAGTGTAGAGAGTTTGTTTATCCCCATACCTTCACACACACAGCCTCCTCCACTATAAACATCCTGCATCACAATGGTGTGTTTGTTATAACTGATCAATCTGCATTGACATATCATTATCATCCAAAGTCCATAGTTGACATTAGGGTTCACTCTTGGTATTGTATATCCAGTTGGTTTTAAGAAATGTGTAATGATATGTATATACCATTACTATATAGTTTTGTATGGTAAAACTACACAATATTTTACTGCTCTAAAAATCCTCTGTCCTCTGCCTACTCATCACTGCCTCCCTATTCTCTGGCAGCCTGTGAGCTTTCTGCTTTAACCAGTTTTGCCATTTCCAGAATGTTT.
And comparing the sequencing results of the PCR products by using biological analysis software MEGA6.0, and analyzing a sequencing peak diagram to finish typing.
4 Statistical analysis
And counting the number of individuals with different genotypes at each site according to the genotyping result. The frequency of g32776109T > C gene, genotype frequency, effective allele (Ne), site heterozygosity (He) and Hardy-Weinberg equilibrium test are calculated by Popgen software, and the polymorphism information content is calculated by PIC (polymorphism information content, PIC for short) calculation software. The correlation of Tibetan sheep different genotypes with immunoglobulin IgA, igG, igM was analyzed using a general linear model in IBM SPSS STATISTICS software, and the results are expressed as "mean ± standard error".
5 Results
5.1 PCR amplification and sequencing results
The amplified product of the SNP locus of the Tibetan sheep chromosome 17 g32776109T > C (see FIG. 1;123 for 3 repeats) is detected by using 1.5% agarose gel, the band is clear and has no impurity band, the specificity is good, the fragment size of the PCR product is 499bp, the expected size is met, and the next experiment can be carried out.
The peak pattern and sequence obtained after the PCR product is purified and sequenced are shown in FIG. 2. As can be seen from FIG. 2, the SNP site of g32776109T > C has T-C mutation, and three genotypes of TT, CT and CC exist.
5.2 Statistical analysis results
Genotype and allele frequency of the Tibetan sheep chromosome 17 g32776109T > C SNP site were analyzed from a population genetics perspective. As can be seen from Table 1, the CC genotype was most frequently found at g32776109T > C SNP site, and the C allele frequency was 94.8% for the dominant genotype, which was expressed as the dominant allele. The SNP sites were significantly deviated from Hardy-Weinberg equilibrium (P < 0.05) as demonstrated by χ 2 fitness test (Table 1). The expected heterozygosity of the locus is 0.099, PIC is 0.094, PIC is less than 0.25, and the locus belongs to low-level polymorphism.
TABLE 1 Tibetan sheep chromosome 17 g32776109T > C SNP site polymorphism
5.3 Correlation analysis of different genotypes and immunoglobulins IgA, igG, igM
The correlation of Tibetan sheep different genotypes and immunoglobulin IgA, igG, igM content is analyzed by using a general linear model in IBM SPSS STATISTICS software, and the result shows that the immunoglobulin IgA, igG, igM of Tibetan sheep individuals with TT genotype is obviously higher than that of Tibetan sheep individuals with CC and TC genotypes (p < 0.05), and the immunoglobulin IgA, igG, igM between the individuals with CC and TC genotypes does not show obvious difference (p > 0.05), which indicates that the base of the Tibetan sheep chromosome 17 g32776109T > C SNP locus is obviously related to Tibetan sheep IgA, igG, igM and is the SNP marker related to Tibetan sheep IgA, igG, igM. The results are shown in Table 2.
TABLE 2 correlation analysis between different genotypes and immunoglobulins IgA, igG, igM
Note that: the same row of data is marked with different lower case letters to indicate that the difference is significant (P < 0.05).
In summary, the SNP molecular marker is positioned at 32776109 th base on chromosome 17 of the international sheep reference genome oar_v4.0 version; the mutation type is T/C, named g32776109T > C, three genotypes exist, and when 32776109 th base on the 17 th chromosome is T, the genotypes are TT or TC; when 32776109 bases on the 17 th chromosome are C, the genotype is CC; through correlation analysis of different genotypes and immunoglobulin IgA, igG, igM content, the immunoglobulin IgA, igG, igM of Tibetan sheep individuals with the TT genotype is found to be significantly higher than that of individuals with CC and TC genotypes (p < 0.05), and the immunoglobulin IgA, igG, igM among individuals with the CC and TC genotypes does not show significant difference (p > 0.05). By detecting the base of 32776109 nucleotide locus on the Tibetan sheep chromosome 17, the immunoglobulin IgA, igG, igM content of Tibetan sheep individuals can be judged, and the invention provides a new SNP molecular marker resource for auxiliary selection of Tibetan sheep immune trait markers for non-diagnostic purposes.
The foregoing is merely a preferred embodiment of the present invention and it should be noted that modifications and adaptations to those skilled in the art may be made without departing from the principles of the present invention, which are intended to be comprehended within the scope of the present invention.
Claims (9)
- The ANKRD50 gene is used as a molecular marker of Tibetan sheep immune traits, and is characterized in that the nucleotide sequence of the molecular marker is shown as SEQ ID NO.1, and the y at the 148 th position of the sequence represents T or C, so that the T/C polymorphism of the Tibetan sheep ANKRD50 gene at the position is caused.
- 2. A primer pair for detecting the molecular marker of claim 1, wherein the nucleotide sequences of the primer pair are shown in SEQ ID nos. 2 and 3.
- 3. A method for detecting a molecular marker associated with an immune trait in Tibetan sheep, comprising the steps of:(1) Extracting Tibetan sheep genome DNA;(2) Amplifying the genomic DNA of step (1) using the primer pair of claim 2;(3) And (3) carrying out typing identification on the polymorphic site of the amplification product obtained in the step (2).
- 4. The method of claim 3, wherein the amplification system of step (2) is: 22. Mu.L of PCR premix, 1. Mu.L of upstream primer, 1. Mu.L of downstream primer and 1. Mu.L of template.
- 5. The method of claim 4, wherein the PCR primer Mix is gold medal Mix.
- 6. The method of claim 3, wherein the amplification procedure of step (2) is: 98 ℃ for 2min;98 ℃ for 10s,57.5 ℃ for 10s and 72 ℃ for 10s, 40 cycles in total; extending at 72℃for 2min.
- 7. Use of the molecular marker of claim 1 or the primer pair of claim 2 or the method of any one of claims 3 to 6 for in vitro detection of an immune trait of Tibetan sheep of non-diagnostic interest.
- 8. Use of the molecular marker of claim 1 or the primer pair of claim 2 or the method of any one of claims 3 to 6 in Tibetan sheep assisted breeding.
- 9. The use according to claim 8, wherein the use is for screening of high immunity Tibetan sheep breeds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410434627.1A CN118166118B (en) | 2024-04-11 | 2024-04-11 | ANKRD50 gene as molecular marker of Tibetan sheep immune trait and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410434627.1A CN118166118B (en) | 2024-04-11 | 2024-04-11 | ANKRD50 gene as molecular marker of Tibetan sheep immune trait and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118166118A true CN118166118A (en) | 2024-06-11 |
CN118166118B CN118166118B (en) | 2024-09-10 |
Family
ID=91350456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410434627.1A Active CN118166118B (en) | 2024-04-11 | 2024-04-11 | ANKRD50 gene as molecular marker of Tibetan sheep immune trait and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118166118B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116287299A (en) * | 2023-02-20 | 2023-06-23 | 民勤同泽农业有限公司 | Molecular marker related to sheep immune traits and application thereof |
CN117683909A (en) * | 2024-01-25 | 2024-03-12 | 中国农业科学院兰州畜牧与兽药研究所 | Molecular marker related to Tibetan sheep immune traits and application thereof |
CN117721221A (en) * | 2024-01-25 | 2024-03-19 | 中国农业科学院兰州畜牧与兽药研究所 | Cloning and application of SNP molecular marker related to Tibetan sheep immune traits |
-
2024
- 2024-04-11 CN CN202410434627.1A patent/CN118166118B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116287299A (en) * | 2023-02-20 | 2023-06-23 | 民勤同泽农业有限公司 | Molecular marker related to sheep immune traits and application thereof |
CN117683909A (en) * | 2024-01-25 | 2024-03-12 | 中国农业科学院兰州畜牧与兽药研究所 | Molecular marker related to Tibetan sheep immune traits and application thereof |
CN117721221A (en) * | 2024-01-25 | 2024-03-19 | 中国农业科学院兰州畜牧与兽药研究所 | Cloning and application of SNP molecular marker related to Tibetan sheep immune traits |
Non-Patent Citations (2)
Title |
---|
佚名: "rs406009602", pages 1, Retrieved from the Internet <URL:https://genome.ucsc.edu/cgi-bin/hgc?hgsid=2307260908_KE1AqWsuo7wzZOMQR8M3mVl2AxXr&db=oviAri4&c=chr17&l=32775961&r=32776460&o=32776108&t=32776109&g=evaSnp5&i=rs406009602> * |
索朗达;巴贵;次仁德吉;德吉;袁超;吴玉江;: "西藏绒山羊KAP7.1和KAP8.2基因多态性及其对部分生产性状的影响", 畜牧与兽医, no. 02, 10 February 2020 (2020-02-10) * |
Also Published As
Publication number | Publication date |
---|---|
CN118166118B (en) | 2024-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kwok et al. | Host genetics and infectious disease: new tools, insights and translational opportunities | |
CN117721221B (en) | Cloning and application of SNP molecular marker related to Tibetan sheep immune traits | |
CN111705140B (en) | SNPs molecular marker related to weight traits and application thereof in Hu sheep assisted breeding | |
CN117904318B (en) | SNP molecular marker related to Tibetan sheep immune traits and application thereof | |
CN116837112B (en) | SNP molecular marker related to yak growth traits and application thereof | |
CN117987569B (en) | Molecular marker related to immune traits and used as auxiliary selection of Tibetan sheep marker and application thereof | |
CN117721220A (en) | Molecular marker related to Tibetan sheep immune traits, detection method and application thereof | |
CN117683909A (en) | Molecular marker related to Tibetan sheep immune traits and application thereof | |
CN107988385B (en) | Method for detecting marker of PLAG1 gene Indel of beef cattle and special kit thereof | |
CN101671736B (en) | Gene detection kit used for detecting cell chimerism or individual recognition | |
CN102816759B (en) | The detection method of Beijing duck STMN1 gene mononucleotide polymorphisms and its molecular labeling | |
CN118166118B (en) | ANKRD50 gene as molecular marker of Tibetan sheep immune trait and application thereof | |
CN118166120B (en) | SNP molecular marker related to Tibetan sheep immune traits and application thereof | |
CN118166117B (en) | Molecular marker for early identification of Tibetan sheep immune traits and application thereof | |
CN115029445B (en) | SNP marker related to weaning weight of merino sheep in alpine and application thereof | |
CN111154892A (en) | Primer pair, kit, method and application for detecting sheep BMPR1B gene insertion/deletion polymorphism | |
CN114657265B (en) | SNP marker for identifying weaning weight of alpine merino sheep and application thereof | |
CN116200528A (en) | SNP molecular marker linked with wheat stripe rust resistance gene QYr.sicau. -2BL and application thereof | |
CN102181582B (en) | Method for detecting classical swine fever resistance character of swine and special kit thereof | |
CN115725722A (en) | Detection reagent and detection kit for identifying bacterial gill disease tolerance of east Asian salmon | |
CN118581234B (en) | Specific primer of Tibetan sheep immunity related gene ATP8A1 molecular marker and application thereof | |
CN118166119A (en) | Tibetan sheep immune trait identification SNP molecular marker and application thereof | |
CN117778594B (en) | SNP molecular marker related to Tibetan sheep immune traits, detection method and application thereof | |
CN118834969A (en) | SNP detection method of Tibetan sheep GRIA3 gene and application of SNP detection method in early immune trait screening | |
CN118813813A (en) | Tibetan sheep molecular marker assisted breeding method with strong disease resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |